全球临床试验影像市场规模、份额、趋势及成长分析报告（2026-2034）

临床试验诊断影像市场预计将从 2025 年的 18 亿美元成长到 2034 年的 37.9 亿美元，2026 年至 2034 年的复合年增长率预计为 8.61%。

受肿瘤学、心臟病学和神经病学领域临床试验数量不断增加的推动，全球临床试验影像市场正在快速扩张。影像在评估治疗效果和监测疾病进展方面发挥着至关重要的作用。製药和生物技术公司越来越多地将影像服务外包给专业供应商。

成长要素包括研发投入增加、对生物标记主导试验的需求不断增长，以及磁振造影（MRI）和电脑断层扫描）等影像技术的进步。监管机构对精确资料收集的重视正在推动标准化成像通讯协定的普及。此外，个人化医疗的兴起也进一步推动了先进影像解决方案的需求。

未来前景光明，人工智慧和云端诊断成像平台的融合将提升数据分析和协作能力。新兴市场临床研究活动的拓展将进一步推动成长。持续的技术进步和不断增长的药物开发平臺有望支撑市场的长期扩张。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球临床试验影像市场：依产品与服务划分

• 市场分析、洞察与预测
• 服务
• 软体

第五章 全球临床试验影像市场：依影像方式划分

• 市场分析、洞察与预测
• 电脑断层扫描
• 磁振造影
• 心臟超音波图
• 核子医学
• 正子断层扫描
• X射线
• 超音波
• 光同调断层扫瞄
• 其他的

第六章 全球临床试验影像市场：依应用领域划分

• 市场分析、洞察与预测
• 肿瘤学
• 神经病学
• 内分泌学
• 心臟病学
• 皮肤科
• 血液学
• 其他的

第七章 全球临床试验影像市场：依最终使用者划分

• 市场分析、洞察与预测
• 製药和生物技术公司
• 受託研究机构
• 医疗设备製造商
• 学术研究机构与政府研究机构
• 其他的

第八章 全球临床试验影像市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Navitas Life Sciences
  • Resonance Health Ltd
  • BioTelemetry（A Philips Company）
  • IXICO Plc
  • ICON Plc
  • Image Core Lab
  • Anagram 4 Clinical Trials
  • Quotient Sciences
  • Radiant Sage LLC
  • Worldcare Clinical
  • Clario
  • Parexel International Corporation
  • Median Technologies
  • Perspectum
  • Invicro LLC

The Clinical Trial Imaging Market size is expected to reach USD 3.79 Billion in 2034 from USD 1.80 Billion (2025) growing at a CAGR of 8.61% during 2026-2034.

The Global Clinical Trial Imaging Market is expanding rapidly due to increasing number of clinical trials in oncology, cardiology, and neurology. Imaging plays a vital role in evaluating treatment efficacy and monitoring disease progression. Pharmaceutical and biotechnology companies are increasingly outsourcing imaging services to specialized providers.

Growth drivers include rising R&D investments, growing demand for biomarker-driven trials, and advancements in imaging modalities such as MRI and CT scans. Regulatory emphasis on accurate data collection has strengthened the adoption of standardized imaging protocols. Additionally, the rise of personalized medicine has further fueled demand for advanced imaging solutions.

Future prospects are promising with integration of AI and cloud-based imaging platforms enhancing data analysis and collaboration. Expansion of clinical research activities in emerging markets will further support growth. Continuous technological advancements and increasing drug development pipelines are expected to sustain long-term market expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product and Services

• Services
• Software

By Modality

• Computed Tomography
• Magnetic Resonance Imaging
• Echocardiography
• Nuclear Medicine
• Positron Emission Tomography
• X-ray
• Ultrasound
• Optical Coherence Tomography
• Others

By Application

• Oncology
• Neurology
• Endocrinology
• Cardiology
• Dermatology
• Hematology
• Others

By End User

• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations
• Medical Device Manufacturers
• Academic and Government Research Institutes
• Others

COMPANIES PROFILED

• Navitas Life Sciences, Resonance Health Ltd, BioTelemetry a Philips Company, IXICO plc, ICON plc, Image Core Lab, anagram 4 clinical trials, Quotient Sciences, Radiant Sage LLC, Worldcare Clinical, Clario, Parexel International Corporation, Median Technologies, Perspectum, Invicro LLC
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CLINICAL TRIAL IMAGING MARKET: BY PRODUCT AND SERVICES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product And Services
• 4.2. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CLINICAL TRIAL IMAGING MARKET: BY MODALITY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Modality
• 5.2. Computed Tomography Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Magnetic Resonance Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Echocardiography Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Nuclear Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Positron Emission Tomography Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. X-ray Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Ultrasound Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.9. Optical Coherence Tomography Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.10. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CLINICAL TRIAL IMAGING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Endocrinology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Dermatology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Hematology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CLINICAL TRIAL IMAGING MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Pharmaceutical and Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Medical Device Manufacturers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Academic and Government Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL CLINICAL TRIAL IMAGING MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product And Services
  • 8.2.2 By Modality
  • 8.2.3 By Application
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product And Services
  • 8.3.2 By Modality
  • 8.3.3 By Application
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product And Services
  • 8.4.2 By Modality
  • 8.4.3 By Application
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product And Services
  • 8.5.2 By Modality
  • 8.5.3 By Application
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product And Services
  • 8.6.2 By Modality
  • 8.6.3 By Application
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL CLINICAL TRIAL IMAGING INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Navitas Life Sciences
  • 10.2.2 Resonance Health Ltd
  • 10.2.3 BioTelemetry (A Philips Company)
  • 10.2.4 IXICO Plc
  • 10.2.5 ICON Plc
  • 10.2.6 Image Core Lab
  • 10.2.7 Anagram 4 Clinical Trials
  • 10.2.8 Quotient Sciences
  • 10.2.9 Radiant Sage LLC
  • 10.2.10 Worldcare Clinical
  • 10.2.11 Clario
  • 10.2.12 Parexel International Corporation
  • 10.2.13 Median Technologies
  • 10.2.14 Perspectum
  • 10.2.15 Invicro LLC